BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38077635)

  • 1. Features of synchronous and metachronous dual primary gastric and colorectal cancer.
    Lin YJ; Chen HX; Zhang FX; Hu XS; Huang HJ; Lu JH; Cheng YZ; Peng JS; Lian L
    World J Gastrointest Oncol; 2023 Nov; 15(11):1864-1873. PubMed ID: 38077635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous?
    Watanabe M; Kochi M; Fujii M; Kaiga T; Mihara Y; Funada T; Tamegai H; Shimizu H; Takayama T
    Am J Clin Oncol; 2012 Oct; 35(5):407-10. PubMed ID: 21659834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor size is an independent risk predictor for metachronous colorectal cancer.
    Kato T; Alonso S; Muto Y; Perucho M; Rikiyama T
    Oncotarget; 2016 Apr; 7(14):17896-904. PubMed ID: 26910116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for metachronous adenoma in patients with stage I/II colorectal cancer after radical surgery.
    Song W; Chen Z; Zheng Z; Zhang Z; Chen Y; He X; Lan P; Hu J; He X
    J Gastrointest Oncol; 2021 Apr; 12(2):535-543. PubMed ID: 34012647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual primary gastric and colorectal cancer: A complex challenge in surgical oncology.
    Marano L
    World J Gastrointest Oncol; 2023 Dec; 15(12):2049-2052. PubMed ID: 38173432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Impact of Synchronous and Metachronous Other Primary Cancer in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Morita J; Segami K; Onodera A; Endo K; Onuma S; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(5):2514-2520. PubMed ID: 36099136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.
    Yoon SN; Oh ST; Lim SB; Kim TW; Kim JH; Yu CS; Kim JC
    World J Surg; 2010 Sep; 34(9):2168-76. PubMed ID: 20532772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
    Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
    Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
    Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
    BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
    Kunitomo A; Ouchi A; Komori K; Kinoshita T; Sato Y; Abe T; Ito S; Sano T; Shimizu Y
    Ann Surg Oncol; 2023 Dec; 30(13):8501-8508. PubMed ID: 37658266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognostic nomogram analysis of patients with dual primary cancers with first gastric cancer: a retrospective study in China.
    Wang B; Liu L
    PeerJ; 2023; 11():e15278. PubMed ID: 37151300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
    Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
    Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of disease-free interval in colorectal cancer: Is it time?
    Birgin E; Doyon F; Burkert J; Téoule P; Rasbach E; Rahbari M; Reissfelder C; Betzler A; Rahbari NN
    Eur J Surg Oncol; 2022 Sep; 48(9):2032-2038. PubMed ID: 35738980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
    Kim C; Chon H; Kang B; Kim K; Jeung HC; Chung H; Noh S; Rha S
    BMC Cancer; 2013 Aug; 13():394. PubMed ID: 23967865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.